Search Results - "KERR, Bradley M"

Refine Results
  1. 1

    Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans by Shah, Vishal, Yang, Chun, Shen, Zancong, Kerr, Bradley M., Tieu, Kathy, Wilson, David M., Hall, Jesse, Gillen, Michael, Lee, Caroline A.

    Published in Xenobiotica (03-07-2019)
    “…The objectives of this study were to determine the absolute bioavailability of lesinurad and to characterized its disposition in humans. The oral…”
    Get full text
    Journal Article
  2. 2

    Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection by HORSMANS, Yves, BERG, Thomas, DESAGER, Jean-Pierre, MUELLER, Tobias, SCHOTT, Eckart, FLETCHER, Simon P, STEFFY, Kevin R, BAUMAN, Lisa A, KERR, Bradley M, AVERETT, Devron R

    Published in Hepatology (Baltimore, Md.) (01-09-2005)
    “…Immune-based therapy is the mainstay treatment for chronic hepatitis C virus (HCV) infection but causes multiple side effects and achieves durable viral…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetic Interactions between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Simvastatin by HSYU, Poe-Hirr, SCHULTZ-SMITH, Melissa D, LILLIBRIDGE, James H, LEWIS, Ronald H, KERR, Bradley M

    Published in Antimicrobial Agents and Chemotherapy (01-12-2001)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics and Safety of an Antirhinoviral Agent, Ruprintrivir, in Healthy Volunteers by HSYU, Poe-Hirr, PITHAVALA, Yazdi K, GERSTEN, Merril, PENNING, Carol A, KERR, Bradley M

    Published in Antimicrobial Agents and Chemotherapy (01-02-2002)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A Population Pharmacokinetic Analysis of Nelfinavir Mesylate in Human Immunodeficiency Virus-Infected Patients Enrolled in a Phase III Clinical Trial by JACKSON, K. A, ROSENBAUM, S. E, KERR, B. M, PITHAVALA, Y. K, YUEN, G, DUDLEY, M. N

    Published in Antimicrobial Agents and Chemotherapy (01-07-2000)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Delavirdine: Clinical pharmacokinetics and drug interactions by TRAN, Jonathan Q, GERBER, John G, KERR, Bradley M

    Published in Clinical pharmacokinetics (2001)
    “…Delavirdine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is a potent and specific inhibitor of HIV-1 reverse transcriptase. The approved…”
    Get full text
    Journal Article
  8. 8

    Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate by LILLIBRIDGE, J. H, BAI HONG LIANG, KERR, B. M, WEBBER, S, QUART, B, SHETTY, B. V, LEE, C. A

    Published in Drug metabolism and disposition (01-07-1998)
    “…In vitro studies with human liver microsomes and P450 probe substrates were performed to characterize selectivity and mechanism of cytochrome P450 inhibition…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetic interaction between amprenavir and delavirdine: Evidence of induced clearance by amprenavir by Tran, Jonathan Q., Petersen, Carolyn, Garrett, May, Hee, Brian, Kerr, Bradley M.

    Published in Clinical pharmacology and therapeutics (01-12-2002)
    “…Objective Our objective was to determine the pharmacokinetic interaction between amprenavir and delavirdine. Methods Healthy volunteers participated in 2…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users by Hsyu, Poe-Hirr, Lillibridge, Jim, Daniels, Elaine, Kerr, Bradley M.

    Published in Biopharmaceutics & drug disposition (01-03-2006)
    “…The effect of nelfinavir 1250 mg twice daily (b.i.d.) on the pharmacokinetics of methadone was determined in 14 HIV‐negative methadone users. Design: The…”
    Get full text
    Journal Article
  11. 11

    Stiripentol in atypical absence seizures in children: an open trial by Farwell, J R, Anderson, G D, Kerr, B M, Tor, J A, Levy, R H

    Published in Epilepsia (Copenhagen) (01-03-1993)
    “…Stiripentol (STP) was added to the antiepileptic drug (AED) regimen of 10 patients with uncontrolled atypical absence seizures (more than one seizure a day)…”
    Get more information
    Journal Article
  12. 12

    Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation by Kerr, B M, Rettie, A E, Eddy, A C, Loiseau, P, Guyot, M, Wilensky, A J, Levy, R H

    Published in Clinical pharmacology and therapeutics (01-07-1989)
    “…On the basis of drug interactions with carbamazepine epoxide, it has been hypothesized that valproic acid and valpromide are inhibitors of epoxide hydrolase,…”
    Get more information
    Journal Article
  13. 13

    Measurement of in vivo microsomal epoxide hydrolase activity in white subjects by Kroetz, D L, Kerr, B M, McFarland, L V, Loiseau, P, Wilensky, A J, Levy, R H

    Published in Clinical pharmacology and therapeutics (01-03-1993)
    “…An impairment or hereditary defect in microsomal epoxide hydrolase is considered a possible risk factor for drug and chemical toxicity. However, nothing is…”
    Get more information
    Journal Article
  14. 14

    Gender Differences in College Students’ Representations of Alcohol in Facebook Status Updates by Kerr, Bradley, MS, Yi, Annie, BS, Moreno, Megan, MD, MPH

    Published in Journal of adolescent health (01-02-2017)
    “…An abstract of a study by Kerr et al exploring the differences in how male and female college students use language to reference alcohol on Facebook is…”
    Get full text
    Journal Article
  15. 15

    Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation by Kerr, B M, Thummel, K E, Wurden, C J, Klein, S M, Kroetz, D L, Gonzalez, F J, Levy, R H

    Published in Biochemical pharmacology (01-06-1994)
    “…A number of drugs inhibit the metabolism of carbamazepine catalyzed by cytochrome P450, sometimes resulting in carbamazepine intoxication. However, there is…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918 by WITHERSPOON, S. M, EMERSON, D. L, KERR, B. M, LLOYD, T. L, DALTON, W. S, WISSEL, P. S

    Published in Clinical cancer research (01-01-1996)
    “…We sought to develop an assay for measuring the inhibition of P-glycoprotein (Pgp) function in whole blood as an indicator of in vivo drug activity. Since the…”
    Get full text
    Journal Article
  19. 19

    Carbamazepine dose requirements during stiripentol therapy: influence of cytochrome P-450 inhibition by stiripentol by Kerr, B M, Martinez-Lage, J M, Viteri, C, Tor, J, Eddy, A C, Levy, R H

    Published in Epilepsia (Copenhagen) (01-03-1991)
    “…The inhibitory effect of stiripentol (STP) on disposition of carbamazepine (CBZ) and carbamazepine-10,11-epoxide (CBZE) was quantitated to establish CBZ dosage…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetics of old, new, and yet-to-be-discovered antiepileptic drugs by Levy, R H, Kerr, B M

    Published in Epilepsia (Copenhagen) (01-01-1989)
    “…The pharmacokinetics of antiepileptic drugs have been investigated extensively during the last two decades. It has become evident that the therapeutic…”
    Get more information
    Journal Article